title: Severe acute hypokalaemia secondary to voriconazole. Uncommon pharmacological causes of hypokalaemia.
authors.forename: M
authors.initials: M
authors.lastname: González Rozas
authors.forename: S
authors.initials: S
authors.lastname: Alvarez Tundidor
authors.forename: M
authors.initials: M
authors.lastname: Pineda Alonso
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use; D000583:Amikacin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D058365:Candidiasis, Invasive / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced* / Q000188:drug therapy; D000069349:Linezolid; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D023303:Oxazolidinones / Q000008:administration & dosage / Q000627:therapeutic use; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000008:administration & dosage / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D011189:Potassium Chloride / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use; D065819:Voriconazole
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D023303:Oxazolidinones; D011743:Pyrimidines; D014230:Triazoles; D000077725:Piperacillin, Tazobactam Drug Combination; D011189:Potassium Chloride; D000583:Amikacin; D010397:Penicillanic Acid; D000069349:Linezolid; D065819:Voriconazole; D010878:Piperacillin